Found 19 matching trials
Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC PHASE2 According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
Neoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal Cancer PHASE3 Objective: Recent randomized and non-randomized studies suggest that neoadj...
Show More Location
Department of Surgical Sciences, University of Torino
Learn More & Join Trial
Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases N/A Published prognostic scores have limitations in prediction of long term sur...
Show More Learn More & Join Trial
Local Radiotherapy Following Complete Resection of a Brain Metastasis NA Objective: To improve local control following complete resection of a singl...
Show More Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Learn More & Join Trial
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction PHASE2 The goal of this study is to evaluate the feasibility and effectiveness of ...
Show More Location
Brigham and Women's Hospital / Dana-Farber Cancer Institute
Learn More & Join Trial
SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC PHASE3 This phase III trial compares the effect of stereotactic radiosurgery and w...
Show More Learn More & Join Trial
Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer PHASE3 Less than 50% of patients receiving salvage radiation therapy (SRT) to the ...
Show More Location
Sahlgrenska University Hospital
Learn More & Join Trial
Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases N/A To observe the quality of life (QOL) and to report on toxicity and outcome ...
Show More Learn More & Join Trial
Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy PHASE3 At present, it is recommended to continue immunotherapy until progression o...
Show More Location
ICO - Site Paul Papin
Learn More & Join Trial
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis PHASE3 This phase III trial evaluates the effect of adding locoregional therapy (s...
Show More Location
Multiple Locations
Learn More & Join Trial